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Abstract. 
 
Dendritic spines are small protrusions on the
 
surface of dendrites that receive the vast majority of
excitatory synapses. We previously showed that the
cell-surface heparan sulfate proteoglycan syndecan-2
induces spine formation upon transfection into hippo-
campal neurons. This effect requires the COOH-termi-
nal EFYA sequence of syndecan-2, suggesting that
cytoplasmic molecules interacting with this sequence
play a critical role in spine morphogenesis. Here, we re-
port a novel protein that binds to the EFYA motif of
syndecan-2. This protein, named synbindin, is ex-
pressed by neurons in a pattern similar to that of synde-
 
can-2, and colocalizes with syndecan-2 in the spines
of cultured hippocampal neurons. In transfected hip-
 
pocampal neurons, synbindin undergoes syndecan-
2–dependent clustering. Synbindin is structurally re-
lated to yeast proteins known to be involved in vesicle
transport. Immunoelectron microscopy localized syn-
bindin on postsynaptic membranes and intracellular
vesicles within dendrites, suggesting a role in postsyn-
aptic membrane trafﬁcking. Synbindin coimmunopre-
cipitates with syndecan-2 from synaptic membrane
fractions. Our results show that synbindin is a physio-
logical syndecan-2 ligand on dendritic spines. We sug-
gest that syndecan-2 induces spine formation by re-
cruiting intracellular vesicles toward postsynaptic sites
through the interaction with synbindin.
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Introduction
 
The functioning of the nervous system depends upon an
immensely complex and precise network of neurons. Cell
adhesion is thought to play a critical role in the formation
and maintenance of synaptic contacts between neurons
(Hall and Sanes, 1993; Rose, 1995; Murase and Schuman,
1999; Serafini, 1999; Shapiro and Colman, 1999). Among
different classes of molecules involved in cell adhesion,
there is evidence that heparan sulfate proteoglycans
(HSPGs)
 
1
 
 are present in central synapses and neuromus-
cular junctions (Bondareff, 1967; Tani and Ametani, 1971;
Eldridge et al., 1986; Cole and Halfter, 1996; Meier et al.,
1998). Furthermore, HSPGs are suggested to play a role in
regulating synaptic strength, thereby acting as key mole-
cules for synaptic stabilization that underlie neural plastic-
ity (Schubert, 1991). Based on these premises, we previ-
ously examined the expression of HSPGs in cultured rat
hippocampal neurons. We demonstrated that syndecan-2,
a member of the syndecan family of HSPGs, is concen-
trated in dendritic spines. Dendritic spines are numerous
small membrane appendages protruding from dendritic
surfaces that consist of specialized postsynaptic structures
for the vast majority of excitatory synapses (Harris and
Kater, 1994). Moreover, we showed that forced expression
of syndecan-2 cDNA in young (1 wk in vitro) hippocampal
neurons induces the formation of morphologically mature
dendritic spines, which are normally seen after 3 wk in
vitro (Ethell and Yamaguchi, 1999).
Syndecans are a major class of membrane-spanning
HSPGs (Bernfield et al., 1992). There is increasing evi-
dence that syndecans play significant roles in the organiza-
tion of specific cell-surface structures, such as focal adhe-
sions, through their interactions with cytoskeletal and
signaling molecules (Carey et al., 1994; Woods and Couch-
man, 1994; Carey, 1997), and thereby provide an impor-
tant linkage between extracellular event and intracellular
signaling. The cytoplasmic domains of syndecans have
structural features that strongly suggest their involvement
in intracellular signaling and cytoskeletal interactions.
These domains consist of a 13-residue juxtamembrane seg-
ment highly conserved among the members (C1 region), a
variable segment, and another highly conserved 7–9-resi-
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due segment (C2 region) at the COOH terminus of the
molecule (Rapraeger and Ott, 1998). Most importantly,
the Glu-Phe-Tyr-Ala (EFYA) sequence located at the
COOH terminus is identical in all syndecans. Moreover,
our previous studies have shown that a syndecan-2 mutant
in which the EFYA sequence was deleted lacks the ability
to induce the formation of dendritic spines, suggesting that
the molecular interactions involving this motif are crucial
for this phenomenon (Ethell and Yamaguchi, 1999).
It has been shown that syndecans interact with two PDZ
domain–containing proteins, syntenin (Grootjans et al.,
1997) and CASK/LIN2A (Cohen et al., 1998; Hsueh et al.,
1998), through the EFYA motif. We previously proposed
a model in which these PDZ domain–containing mole-
cules are potential downstream effectors of syndecan-2 in
dendritic spines (Ethell and Yamaguchi, 1999). In this
model, we suggested that the spine formation is mediated
by the cytoskeletal reorganization initiated by the synde-
can-2–dependent clustering of PDZ domain proteins. In
this paper, we report a novel syndecan-binding protein,
synbindin. Unexpectedly, the structural property and the
localization of synbindin suggest an entirely different
mechanism for syndecan-2–induced spine formation.
Synbindin is a neuronal cytoplasmic protein identified
by yeast two-hybrid screening using the syndecan-2 cyto-
plasmic domain as a bait. Although it bears homologies
with several PDZ domain proteins and binds to the
COOH-terminal EFYA tail of syndecan-2 (as do CASK
and syntenin), synbindin does not contain any classical
PDZ domains. Rather, synbindin shares homologies with
yeast proteins involved in membrane trafficking and vesi-
cle transport acting upstream of the soluble NSF attach-
ment protein receptor (SNARE) complex. There is in-
creasing evidence that functional postsynaptic maturation
involves the regulation of vesicle trafficking in postsynap-
tic sites (Lledo et al., 1998; Turner et al., 1999). Dendritic
spines contain intracellular membrane-bound cisterns,
known as spine apparatus (Villa et al., 1992), which are
frequently seen in the vicinity of the postsynaptic density
(Harris and Stevens, 1988; Spacek and Harris, 1997). Syn-
bindin is identified in vesicles in dendritic spines as well as
in synapses. Furthermore, synbindin forms clusters in den-
dritic spines when syndecan-2 is coexpressed in neurons.
Our observations suggest a role for cell-surface synde-
can-2 in the translocation of postsynaptic vesicular com-
partments through the cytoplasmic interaction with this
novel syndecan-2–binding molecule.
 
Materials and Methods
 
Yeast Two-Hybrid Assays
 
Yeast two-hybrid screens were performed using the L40 yeast strain,
where the expression of both the reporter genes HIS3 and LacZ are
driven by minimal GAL1 promoters fused to LexA-binding sites. A bait
consisting of the entire cytoplasmic domain of the syndecan-2 fused in-
frame to the LexA DNA–binding domain was constructed by PCR with
the BTM116 vector. An embryonic mouse cDNA library constructed into
the NotI site of pVP16 containing the Leu2 activation domain (Vojtek and
Hollenberg, 1995; a gift from Dr. Erkki Ruoslahti, The Burnham Insti-
tute) was screened with the syndecan-2 bait. Positive clones were selected
by His prototrophy and assayed for 
 
b
 
-galactosidase activity. Double-posi-
tive clones were isolated and characterized by sequencing. A double-posi-
tive clone (clone 28), which encodes a putative cytoplasmic protein with
 
similarities to several PDZ domain–containing proteins (see Results), was
further investigated as described in this paper. We named this protein syn-
bindin. The specificity of the interaction between synbindin and the cyto-
plasmic domain of syndecan-2 was analyzed by two-hybrid assays (see Fig.
1 A). For this, we generated (by PCR) the following additional baits of the
syndecan cytoplasmic domains: (1) a syndecan-2 deletion mutant lacking
the COOH-terminal EFYA sequence (syndecan-2
 
D
 
EFYA); (2) a synde-
can-4 deletion mutant lacking the COOH-terminal EFYA sequence (syn-
decan-4
 
D
 
EFYA); and (3) a bait with reverse sequence of syndecan-2 cyto-
plasmic domain. To determine the syndecan-2–binding site in synbindin,
we generated by PCR four Leu2 fusion constructs representing the NH
 
2
 
-
terminal half of synbindin (N-Sbd), the PDZ-related domain (P-Sbd), the
COOH-terminal half (C-Sbd), and the PDZ-related domain plus the
COOH-terminal half (P/C-Sbd) (see Fig. 2 D). Two-hybrid assays were
performed as described above using HIS3 and LacZ as reporter genes.
 
Cloning of the Full-length Synbindin cDNA
 
The full-length synbindin cDNA was isolated from a mouse brain 
 
l
 
ZAP
cDNA library (Stratagene) with clone 28 as a probe. Four cDNA clones
were isolated. One of the isolated clones contained an entire open reading
frame encoding 219 amino acid residues. Full-length sequence of mouse
synbindin cDNA was determined from this clone. Human and 
 
Cae-
norhabditis elegans
 
 synbindin homologues were identified in EST data-
base by a BLAST search, and their entire sequences were reconstituted
from overlapping EST clones.
 
Production of Glutathione-S-Transferase (GST)
Fusion Proteins
 
A 663-bp EcoRI-XhoI fragment containing the entire coding region of
mouse synbindin was amplified by PCR with the following primers and li-
gated into pGEX-4T-1 (Amersham Pharmacia Biotech): 5
 
9
 
 primer,
ACCCGGAATTCATGGCGATTTTTACCGTGTAC; and 3
 
9
 
 primer,
CGGCCGCTCGAGCTATGACCCAGGTCCAAAAGT. The GST-syn-
bindin expression plasmid as well as insertless pGEX-4T-1 were trans-
fected into BL21 
 
Escherichia coli
 
 strains according to the manufacturer’s
instructions. BL21 cells were lysed by sonication in 20 mM Tris-HCl con-
taining 0.15 M NaCl, 1 mM EDTA, 1 mM PMSF, 10 
 
m
 
g/ml pepstatin, 10
 
m
 
g/ml aprotinin, and 2 
 
m
 
g/ml leupeptin. Sarkosyl was added to lysates to a
final concentration of 1.5%, and the lysates were gently mixed for 15 min.
After centrifugation, supernatants were adjusted to 2% Triton X-100 and
1 mM CaCl
 
2
 
, and GST-synbindin was purified with glutathione-agarose.
 
Antibodies
 
Two polyclonal antibodies against mouse synbindin were generated for
this study. Rabbit anti-synbindin peptide antibody was raised against a
synthetic peptide acetyl-CELFDQNLKLALELAEKV-amide (corre-
sponding to amino acids 195–213 of mouse synbindin) and affinity-puri-
fied on amino-link/agarose beads coupled with the synthetic peptide
(Quality Controlled Biochemicals). The other polyclonal antibody (No.
157) was raised against the bacterially produced recombinant synbindin
protein released from GST-synbindin fusion protein by proteolytic cleav-
age and affinity-purified using synbindin-GST fusion protein coupled to
glutathione-agarose. Other antibodies used in this study were as follows:
anti–c-Myc rabbit polyclonal antibody A14 (Santa Cruz Biotechnology,
Inc.); anti–syndecan-2 mAb 6G12 (Lories et al., 1989; a gift from Dr.
Guido David, University of Leuven, Leuven, Belgium); anti–syndecan-2
polyclonal antibody (Kim et al., 1994; a gift from Dr. Merton Bernfield,
Harvard Medical School, Boston, MA); anti–PSD-95 mAb 6G6 (Affinity
Bioreagents, Inc.); antisynaptophysin and anti-MAP2 mAbs (Sigma
Chemical Co.); and anti-CASK polyclonal antibody (Hsueh et al., 1998; a
gift from Dr. Morgan Sheng, Howard Hughes Medical Institute, Harvard
Medical School, Boston, MA).
 
Transfection of 293 Cells, GST Pull-down, and 
Coimmunoprecipitation Experiments
 
Human 293 cells were grown in DME supplemented with 10% FCS and
antibiotics. Approximately 70% confluent 293 cells in 10-cm dishes were
transfected with 20 
 
m
 
g of an expression vector for Myc-tagged full-length
syndecan-2 (a gift from Dr. Morgan Sheng; Hsueh et al., 1998) or a control
vector using the calcium phosphate method (Ethell and Yamaguchi,
1999). 1 d after transfection, transfected cells were treated with or without 
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heparitinase (Seikagaku America), and then sonicated in 25 mM Tris-
HCl, pH 8.0, containing 0.15 M NaCl, 1% Triton X-100, 5 mM EDTA, 1
mM PMSF, 5 mM DTT, 10 
 
m
 
g/ml pepstatin, 10 
 
m
 
g/ml aprotinin, and 2 
 
m
 
g/
ml leupeptin (lysis buffer). Heparitinase treatment was performed in 20
mM Hepes, pH 7.0, containing 0.15 M NaCl and 1 mM calcium acetate for
1 h at 37
 
8
 
C. After sonication, cell lysates were cleared by centrifugation at
14,000 rpm in a microcentrifuge. For pull-down assays, cleared lysates
were incubated with glutathione-agarose beads charged with unfused
GST or GST-synbindin fusion protein for 1 h at 4
 
8
 
C. After incubation,
beads were washed once with lysis buffer and five times with 25 mM Tris-
HCl, pH 7.4, containing 0.5 M NaCl and 0.2% Triton X-100 at room tem-
perature. The materials retained on the beads were eluted with SDS-
PAGE sample buffer and detected by SDS-PAGE and immunoblotting as
described previously (Belliveau et al., 1997). The Myc-tagged syndecan-2
pulled down by GST-synbindin was detected with either anti–syndecan-2
mAb (clone 6G12; a gift from Dr. Guido David; 1:1,000 dilution) or anti-
Myc polyclonal antibody (A14; Santa Cruz Biotechnology; 1:1,000 dilu-
tion).
For coimmunoprecipitation assays, we generated intact and 
 
D
 
EFYA
syndecan-2 cDNAs that are epitope-tagged with the FLAG sequence
(designated as FLAG-syndecan-2 and FLAG-syndecan-2
 
D
 
EFYA, respec-
tively). A FLAG tag (DYKDDDDK) was inserted at the unique SpeI site
in the ectodomain of syndecan-2. These FLAG-tagged syndecan-2 con-
structs were transfected into 293 cells with or without cotransfection of a
synbindin expression construct in which the c-Myc epitope was added to
the NH
 
2
 
 terminus of synbindin (Myc-synbindin). Cell lysates from these
transfectants were prepared as described above without heparitinase
treatment. The lysates were incubated with the A14 anti-Myc polyclonal
antibody for 2 h at 4
 
8
 
C, followed by an incubation with protein A–Seph-
arose for 1 h. Bound materials were eluted with SDS-PAGE sample
buffer, separated on an 8–16% gel, and immunoblotted with the M2 anti-
FLAG mAb (Sigma Chemical Co.; 1:1,000 dilution) to detect coprecipi-
tated FLAG-tagged syndecan-2.
 
Production of Hexahistidine (His)-tagged Syndecan-2 
Cytoplasmic Domains and Overlay Assays
 
For preparation of His-tagged syndecan-2 cytoplasmic domains, a DNA
fragment encoding the entire syndecan-2 cytoplasmic domain was am-
plified by PCR and inserted into EcoRI-XhoI–linearized pET-30a
(Novagen). The construct for His-tagged 
 
D
 
EFYA syndecan-2 cytoplasmic
domain was then generated by point mutagenesis of the AAG codon for
the lysine residue preceding the EFYA sequence to a stop codon (TAG).
These His-tagged cytoplasmic domains (intact and 
 
D
 
EFYA) were ex-
pressed in BL21 (DE3) cells and purified on ProBond resin (Invitrogen).
For overlay assays, equal amounts of the intact and 
 
D
 
EFYA cytoplasmic
domains were loaded on a 10–20% tricine gel and blotted onto a nitrocel-
lulose membrane. The membrane was stained with Ponceau S to ascertain
that equivalent amounts of the intact and 
 
D
 
EFYA cytoplasmic domains
were applied. The membrane was blocked with 5% nonfat dry milk in 25
mM Tris-HCl, pH 7.4, containing 0.15 M NaCl and 0.3% Tween 20 (TBS-
Tween) overnight at 4
 
8
 
C, and incubated with 50 
 
m
 
g/ml of purified GST-
synbindin in TBS-Tween containing 1 mM DTT and 2% BSA for 2 h at
room temperature. Bound GST-synbindin was detected with goat anti-
GST antibody (Amersham Pharmacia Biotech; 1:3,000 dilution) and
HRP-conjugated anti-goat IgG (Sigma Chemical Co.; 1:5,000 dilution).
 
Primary Cultures and Transfection of Hippocampal 
Neurons
 
Cultures of rat hippocampal neurons were prepared as described previ-
ously from E17 embryos (Ethell and Yamaguchi, 1999). Transient trans-
fection of hippocampal neurons was performed at 1 d in vitro by the cal-
cium phosphate coprecipitation method (Ethell and Yamaguchi, 1999).
For the analysis of coclustering of syndecan-2 and synbindin, hippocampal
neurons were transfected with an expression vector containing synbindin-
green fluorescent protein (GFP) fusion protein alone, or together with ei-
ther the full-length syndecan-2 expression vector or the syndecan-
2
 
D
 
EFYA expression vector (for detail of these vectors see Ethell and
Yamaguchi, 1999). Cotransfection of the synbindin-GFP and the synde-
can-2/syndecan-2
 
D
 
EFYA expression vectors were performed at the ratio
of 1:10 (Ethell and Yamaguchi, 1999). We confirmed that, under this con-
dition, essentially every GFP-positive cell coexpresses syndecan-2/synde-
can-2
 
D
 
EFYA as demonstrated by immunostaining for syndecan-2. The
frequency of synbindin clustering in these cotransfected cultures was de-
 
termined as the percentage of cells that show 
 
.
 
10 synbindin clusters in
their dendrites to the total GFP-positive cells. A total of 40 neurons were
scored in four sampling windows for each culture.
 
Immunofluorescence and Confocal Imaging
 
Hippocampal neurons transfected with synbindin-GFP alone or together
with syndecan-2 were examined 8 d after transfection (9 DIV) by a confo-
cal microscopy as previously described (Ethell and Yamaguchi, 1999).
Synbindin localization was identified by GFP fluorescence. Transfected
neurons were also immunostained with either anti–synapsin I polyclonal
antibody (1:100 dilution; a gift from Dr. Andrew Czernik), anti–synde-
can-2 polyclonal antibody (1:100 dilution; a gift from Dr. Merton Bern-
field) or anti-MAP2 mAb (1:100 dilution; Sigma Chemical Co.).
Rhodamine-conjugated anti-rabbit IgG (1:100 dilution; Chemicon Inter-
national) or rhodamine-conjugated anti-mouse IgG (1: 50 dilution; Cappel
Laboratories) were used as secondary antibodies.
To localize endogenous synbindin, hippocampal neurons at 1, 2, 3, and
4 wk in vitro were double-immunostained with affinity-purified antisyn-
bindin polyclonal antibody (No. 157; 1:100 dilution) and antisynapto-
physin mAb (1:100 dilution; Sigma Chemical Co.) or antisynbindin poly-
clonal antibody and anti-MAP2 mAb (1:100 dilution; Sigma Chemical
Co.). FITC-conjugated anti-rabbit IgG (1:100 dilution; Chemicon Interna-
tional) and rhodamine-conjugated anti-mouse IgG (1:50 dilution; Cappel
Laboratories) were used as secondary antibodies. After staining, cells
were mounted with fluorescence H-1000 medium (Vector Laboratories)
and analyzed on a confocal laser scanning microscope (model MRC1024;
Bio-Rad Laboratories).
 
RNA Purification, Reverse Transcriptase (RT)-PCR, 
and Northern Blot Analysis
 
Total RNA was extracted from cultures of rat hippocampal neurons at dif-
ferent time points by using Trizol reagents (Life Technologies, Inc.). RT-
PCR was performed with 2 
 
m
 
g of the total RNA with the following primer
pair: 5
 
9
 
 primer, GAGGCTGAGAAGACTTTCAG; 3
 
9
 
 primer, AAC-
ATCGAGGCCAGCATAAG (corresponding to nucleotide numbers
291–311 and 537–557 of mouse synbindin, respectively). PCR products
were analyzed on an agarose gel. The identity of amplified bands as syn-
bindin was confirmed by sequencing. For Northern analysis, a mouse mul-
tiple tissue Northern blot (CLONTECH Laboratories, Inc.) was hybrid-
ized with a 
 
32
 
P-labeled RNA probe of mouse synbindin, which was
synthesized with T3 RNA polymerase (Promega) using pBluescript II
SK
 
1
 
 containing mouse synbindin cDNA as a template. Hybridization was
performed according to the manufacturer’s instructions.
 
In Situ Hybridization
 
Adult C57BL/6 mice were anesthetized and perfused transcardially with
4% paraformaldehyde in PBS. Whole brains were dissected, immersed in
30% sucrose in PBS overnight at 4
 
8
 
C, and embedded in OCT compound
(Miles). Cryostat sections (20-
 
m
 
m thick) were hybridized with digoxige-
nin-labeled RNA probes as described previously (Watanabe et al., 1995).
Antisense and sense RNA probes for mouse synbindin and syndecan-2
were in vitro transcribed from pBluescript II SK
 
1
 
 containing full-length
synbindin or syndecan-2 cDNA using either T3 or T7 RNA polymerase
(Promega) and the digoxigenin RNA labeling kit (Boehringer Mann-
heim).
 
Subcellular Fractionation and Coimmunoprecipitation 
of Endogenous Proteins
 
Subcellular fractions of adult mouse cortex or hippocampus were pre-
pared as described by Li et al. (1996) and Torres et al. (1998). In brief,
adult mouse cortex was homogenized in 4 mM Hepes, pH 7.4, containing
0.32 M sucrose, 1 mM PMSF, 10 
 
m
 
g/ml pepstatin, 10 
 
m
 
g/ml aprotinin, and
2 
 
m
 
g/ml leupeptin with a Teflon head tissue grinder. Homogenates were
centrifuged at 1,000 
 
g
 
 for 10 min. The supernatant was collected and cen-
trifuged at 12,000 
 
g
 
 for 15 min, yielding a pellet (P2) and supernatant (S2).
Supernatant (S2) was further centrifuged at 100,000 
 
g
 
 for 90 min. The re-
sulting supernatant represents the soluble fraction. The P2 pellet was re-
suspended in homogenization buffer and represented crude synaptosomes
fraction. The crude synaptosome fraction was lysed by osmotic shock by
adding 10 vol of ice-cold water containing protease inhibitors and homog-
enized. The synaptic membrane fraction was pelletted from this homoge- 
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nate by centrifugation at 33,000 
 
g
 
 for 20 min, and the supernatant con-
tained synaptic vesicles. Equal amounts of proteins (50 
 
m
 
g per lane) from
each fraction were resolved by SDS-PAGE on an 8–16% gradient gel,
transferred to a nitrocellulose membrane, and analyzed by immunoblot-
ting. The subcellular fractions were examined by immunoblotting with
anti–PSD-95 (a marker for postsynaptic density), antisynaptophysin (a
marker for synaptic vesicles), and anti-CASK antibodies. To identify sub-
cellular localization of synbindin, the subcellular fractions were probed
with antisynbindin peptide antibody at 1:500 dilution. As a control for
specificity of antisynbindin antibody, blots were reprobed with preim-
mune serum.
For coimmunoprecipitation of synbindin and syndecan-2 from the
brain, the synaptic membrane fraction was solubilized with 1% CHAPS in
TBS containing a protease inhibitor cocktail (Sigma Chemical Co.). After
removing insoluble materials by centrifugation, supernatants were incu-
bated with protein G–Sepharose charged with anti–syndecan-2 mAb
(6G12) or uncharged protein G–Sepharose at 4
 
8
 
C for 2 h. Bound materi-
als were eluted with SDS-PAGE sample buffer, separated on a 8–16% gel,
and immunoblotted with antisynbindin polyclonal antibody (No. 157).
 
Immunohistochemistry and
Immunoelectron Microscopy
 
Immunohistochemistry of synbindin was performed with free-floating sec-
tions. In brief, adult mice were perfused transcardially with ice-cold 0.9%
saline followed by fixation in 4% paraformaldehyde. Free-floating Vi-
bratome sections (50–100-mm thick) of the whole brain were first washed
in 0.1 M Tris-HCl, pH 7.6, incubated with 1% hydrogen peroxide for 30
min, and washed again with 50 mM Tris-HCl, pH 7.6, containing 0.15 M
NaCl (TBS). Sections were blocked for 30 min with TBS containing 0.1%
Triton X-100, 3% normal goat serum and 0.1% BSA (blocking buffer),
and then with the avidin-biotin blocking kit (Vector Laboratories).
Blocked sections were incubated with affinity-purified antisynbindin anti-
body (No. 157), which was diluted in the blocking buffer at 2 
 
m
 
g/ml at
room temperature overnight. After washing with TBS containing 0.1%
Triton X-100 (TBS-T), sections were incubated with biotinylated goat
anti–rabbit antibody (Vector Laboratories) at a dilution of 1:200 for 2 h,
washed with TBS-T, and incubated with avidin-biotin HRP complex
(Vectastain Elite; Vector Laboratories) for 2 h at room temperature. Af-
ter washing with TBS-T and with 50 mM Tris-HCl, pH 7.6, sections were
reacted with 0.05% diaminobenzidine and 0.001% hydrogen peroxide
in TBS.
For electron microscopy, adult mice were perfused through the aorta
with ice-cold 0.9% NaCl and then with 4% glutaraldehyde and 0.1%
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4. The brain was dis-
sected and postfixed in the same fixative for 1 h at room temperature, and
coronal sections (100 
 
m
 
m) of the cerebral cortex were cut by Vibratome.
Preembedding immunostaining was performed as follows: the sections
were cut into small pieces and incubated in PBS containing 50 mM glycine
for 5 min, washed three times with PBS, and blocked with PBS containing
20% normal goat serum and 0.05% Triton X-100 for 1 h. Blocked sections
were incubated with affinity-purified antisynbindin antibody (No. 157) or
normal rabbit IgG (as a negative control) diluted in PBS containing 3%
normal goat serum, 0.05% Triton X-100 (PBS-T) overnight. The next day,
sections were washed three times with PBS-T and incubated with anti-rab-
bit nanogold conjugates (1.4 nm; Nanoprobes Inc.) at a dilution of 1:100 in
PBS-T for 90 min at room temperature. After four washes with PBS-T,
the sections were further washed four times with deionized water and
treated for 7 min with gold enhancer-EM formulation (Nanoprobes Inc.)
to enhance immunoreactive signals. The sections were postfixed in 1% os-
mium in PBS for 30 min, washed with PBS, dehydrated through graded
ethanol solutions, and infiltrated with propylene oxide to Epon resin (Ted
Pella). The sections were sandwiched between strips of ACLAR plastic
film (Ted Pella), flattened between glass sheets, and polymerized in Epon
Araldite at 60
 
8
 
C for 24 h. Epon-embedded samples were glued onto resin
blocks, and ultrathin sections were cut and collected on 200-mesh collo-
dion-coated copper grids (Electron Microscopy Sciences). The grids were
poststained with uranyl acetate and lead citrate, and examined on a Hi-
tachi 600E transmission electron microscope. The distribution of gold par-
ticles was analyzed by counting particles using NIH Image software as de-
scribed in Srivastava et al. (1998).
 
Results
 
Identification and Cloning of a Novel
Syndecan-2–binding Protein, Synbindin
 
To identify novel syndecan-2–binding proteins, we per-
formed a yeast two-hybrid screen using the syndecan-2 cy-
toplasmic domain as bait. Screening of a mouse embryo li-
brary resulted in isolation of positive colonies selected by
HIS prototrophy and 
 
b
 
-galactosidase activity. One of the
isolates (clone 28) showed a strictly specific interaction
pattern with a series of control baits. The specificity of the
interaction between clone 28 and the syndecan cytoplas-
mic domain was studied further by two-hybrid assays (Fig.
1, A and B). This study demonstrated that clone 28 recog-
nizes the COOH-terminal EFYA sequence of syndecans.
As shown in Fig. 1, clone 28 binds not only the syndecan-2
domain, but also the syndecan-4 cytoplasmic domain, sug-
gesting that it recognizes a region conserved in both syn-
decans. Because syndecan-2 and syndecan-4 share the
COOH-terminal EFYA motif, we deleted this motif from
baits (designated as syndecan-2
 
D
 
EFYA and syndecan-
4
 
D
 
EFYA, respectively). Both syndecan-2
 
D
 
EFYA and
syndecan-4
 
D
 
EFYA mutants failed to bind clone 28 (Fig. 1
B). These results indicate that it binds to the COOH ter-
minus of syndecans, as do syntenin and CASK.
A full-length cDNA for this gene was isolated from a
mouse brain library. The entire open reading frame en-
codes a protein consisting of 219 amino acid residues with
a predicted molecular mass of 
 
z
 
24 kD (Fig. 1 C). The
clones isolated by two-hybrid screening corresponded to
amino acid residues 18–182 of this protein. No signal se-
quence or transmembrane domain was identified in the
protein. We named this protein synbindin. Synbindin has
48% amino acid identity with the 
 
C
 
.
 
 elegans
 
 F36D4.2 gene
(U53181) and 29% identity with a 23-kD yeast protein,
tentatively called p23 (Sacher et al., 1998; Fig. 1, C and D).
These 
 
C. elegans
 
 and yeast proteins are likely to be ortho-
logues to mouse synbindin, suggesting that synbindin is
highly conserved across species. While no functional data
are available for the
 
 C. elegans
 
 gene, the yeast p23 is a
component of a multiprotein complex (transport protein
particle [TRAPP]) involved in vesicle docking and fusion
(Sacher et al., 1998). This suggests that synbindin may be
involved in vesicular transport in mammalian cells.
A homology search further identified three segments of
substantial homology with proteins known to be involved
in vesicular transport as well as synaptic functions (Fig. 1,
F). First, an 
 
z
 
60-amino acid residue segment in the NH
 
2
 
-
terminal part of synbindin bears homologies with several
PDZ domains. Weak but significant homologies (20–30%
identity; 40–50% similarity) were identified with the fol-
lowing: the sixth PDZ domain of glutamate receptor–inter-
acting protein (GRIP) 1 and GRIP2 (Dong et al., 1997;
Srivastava et al., 1998; Wyszynski et al., 1999); the seventh
PDZ domain of the 5-HT
 
2C
 
 receptor–binding protein
MUPP1 (Ullmer et al., 1998); the fourth PDZ domain of
human INAD-like protein (Phillipp and Flockerzi, 1997);
and the second PDZ domains of Mint-1, -2, and -3 (Duclos
et al., 1993; Okamoto and Südhof, 1997; Takahashi and Ta-
bira, 1999). All of these proteins have been implicated in
synaptic functions. The homology with these PDZ domains 
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does not encompass the entire PDZ domain, but is re-
stricted to the COOH-terminal part of the domain. There-
fore, this segment of synbindin does not constitute a classi-
cal PDZ domain. Second, a 76-amino acid residue segment
in the middle of the molecule shows a strong similarity with
the yeast gene BET5 (Fig. 1 F). BET5 is a gene involved in
vesicle transport in yeast. A null mutation of BET5 blocks
ER-to-Golgi transport (Jiang et al., 1998). Moreover, like
p23, the protein product of BET5 (Bet5p) is a component
of the yeast TRAPP complex (Jiang et al., 1998). Consider-
ing the phylogenetic distance between mouse and yeast,
the homology between synbindin and BET5 in this seg-
ment is quite high (30% identity; 50% similarity). These
observations further supports the notion that synbindin is
involved in vesicular transport. Finally, the 35 residue
COOH-terminal segment shows 45% identity (52% simi-
larity) to a short cytoplasmic segment of the cardiac muscle
ryanodine receptor (RyR-2), which is a calcium release
channel on the membrane of intracellular Ca
 
2
 
1
 
 stores
(Tunwell et al., 1996). Taken together, synbindin consists
of four regions: the NH
 
2
 
-terminal region, which has no sig-
nificant homology with any known proteins; a PDZ-related
region; a BET5-related region; and a COOH-terminal tail
similar to a short segment of RyR-2 (Fig. 1 E)
 
Characterization of the
Synbindin–Syndecan-2 Interaction
 
To further assess the specificity of the synbindin–synde-
can-2 interaction, we performed pull-down and coimmu-
noprecipitation assays. For pull-down assays, glutathione-
agarose beads charged with synbindin-GST fusion protein
or nonfused GST were incubated with lysates of 293 cells
expressing Myc-tagged syndecan-2. Bound materials were
probed by immunoblotting with anti–syndecan-2 mAb or
anti-Myc polyclonal antibody (Fig. 2 A). (Note that, in 293
cells, most syndecan-2 molecules are expressed as a 34-kD
simple glycoprotein lacking heparan sulfate chains [see
Fig. 2, A, d].) As shown in Fig. 2, GST-synbindin brought
down syndecan-2 from the cell lysates (Fig. 2 A, a and b).
No syndecan-2 was brought down with nonfused GST
(Fig. 2 A, c) or from control transfected 293 cells (Fig. 2 A,
a and b, lane 1). To examine coimmunoprecipitation of
synbindin and syndecan-2, 293 cells were cotransfected
with FLAG-tagged syndecan-2 (either FLAG-syndecan-2
or FLAG-syndecan-2
 
D
 
EFYA) and Myc-tagged synbindin.
The FLAG-syndecan-2 was precipitated from the lysate of
cotransfected cells with anti-Myc antibody (Fig. 2 B, c,
 
(AAA93486), and the yeast p23 (Sacher et al., 1998). Identical
amino acid residues are shown in a box. The nucleotide sequence
data of mouse synbindin is available from GenBank/EMBL/
DDBJ under accession number AF233340. (D) Percent amino
acid identity between mouse synbindin and its human, nematode,
and yeast homologues. (E) A model of the synbindin molecule.
Each box represents a region that shows homology with the
known protein(s) indicated below the box. Numbers indicate
amino acid residues. (F) Alignment of mouse synbindin (
 
Sbd
 
)
with human GRIP1 (AJ133439) and rat GRIP2 (AF112182), hu-
man MUPP1 (AF093419) and human INAD (AJ001306), rat
Mint1 (AF029105) and human Mint2 (AF029108), yeast BET5
(NP_013634), and human RyR-2 (X98330). 
 
Figure 1.
 
Synbindin is a novel protein that interacts with the
EFYA motif of syndecans. (A and B) Binding of clone 28 (syn-
bindin) to the syndecan cytoplasmic domains. Two-hybrid assays
were performed with the Leu2 activation domain containing
clone 28 and the LexA DNA–binding domain containing one of
following syndecan cytoplasmic domains: syndecan-2 (1); synde-
can-4 (2); a scrambled amino acid sequence of syndecan-2 (3);
syndecan-4
 
D
 
EFYA (4); and syndecan-2
 
D
 
EFYA (5 and 6). Trans-
formants were grown on a Leu
 
2
 
/Trp
 
2
 
 plate (A) or a His
 
2
 
/Leu
 
2
 
/
Trp
 
2
 
 plate (B). (C) Amino acid sequences of mouse synbindin
deduced from its full-length cDNA sequence in comparison with
the putative human synbindin (AAF21897.1), 
 
C
 
.
 
 elegans
 
 F36D4.2 
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lane 2). No coimmunoprecipitation was observed when
synbindin was not introduced into cells (Fig. 2 B, c, lane 1).
The syndecan-2
 
D
 
EFYA mutant was not coprecipitated
with synbindin (Fig. 2 B, c, lane 3).
Direct binding between synbindin and the syndecan-2
cytoplasmic domain was examined using purified His-
tagged syndecan-2 cytoplasmic domains and GST-synbin-
din. GST-synbindin bound to His-tagged syndecan-2 cyto-
plasmic domain in the overlay assay (Fig. 2 C). Consistent
with pull-down and coimmunoprecipitation assays, the 
 
D
 
E-
FYA cytoplasmic domain failed to bind GST-synbindin. 
Finally, we analyzed the region of synbindin that inter-
acts with syndecan-2 by using two-hybrid assays. The full-
length synbindin and four truncated forms were tested
with baits of the intact and 
 
D
 
EFYA syndecan-2 cytoplas-
mic domains (Fig. 2 D). The three fragments containing
the PDZ-like segment showed a strong interaction with
the intact syndecan-2 cytoplasmic domain. The strongest
of the three was the P-Sbd fragment, which consists only of
the PDZ-like segment followed by the N-Sbd and P/C syn-
bindin fragments. The fragment without the PDZ-like seg-
ment (C-Sbd) did not display a signal above background.
The 
 
D
 
EFYA bait did not interact with any fragments.
Taken together, these binding studies establish that syn-
 
Figure 2.
 
Characterization of the synbindin–syndecan-2 interac-
tion by pull-down, coimmunoprecipitation, ligand overlay, and
two-hybrid assays. (A) GST pull-down assay. Lysates from hu-
man 293 cells transfected with Myc-tagged syndecan-2 were
pulled down with GST-synbindin fusion protein (a and b) or non-
fused GST (c) and immunoblotted with anti–syndecan-2 mAb
6G12 (a) or anti-Myc polyclonal antibody A14 (b and c). In d,
cell lysates were directly immunoblotted with anti–syndecan-2
mAb without pull-down. In each panel, three different lysates
were tested: (lane 1) lysates from 293 cells transfected with a con-
trol vector; (lane 2) lysates from 293 cells transfected with Myc-
tagged syndecan-2, which were undigested; and (lane 3) lysates
from 293 cells transfected with Myc-tagged syndecan-2, which
were digested with heparitinase. The arrowhead indicates the 34-
kD syndecan-2 core protein. (B) Coimmunoprecipitation of syn-
bindin and syndecan-2. The 293 cells were transfected with
FLAG-syndecan-2 alone (lane 1), FLAG-syndecan-2 and Myc-
synbindin (lane 2), or the FLAG-syndecan-2
 
D
 
EFYA deletion
mutant and Myc-synbindin (lane 3). The cell lysates were immu-
noprecipitated with anti-Myc polyclonal antibody and immuno-
blotted with anti-FLAG antibody (c). The arrowhead indicates
the syndecan-2 core protein. Note that the intact syndecan-2 was
coimmunoprecipitated with synbindin (c, lane 2), whereas the
syndecan-2
 
D
 
EFYA deletion mutant was not (c, lane 3). In a and
b, the lysates were directly immunoblotted with anti-Myc anti-
body (a) and anti-FLAG antibody (b), respectively, to show that
similar amounts of proteins were expressed. (C) GST-synbindin
overlay assay. His-tagged recombinant proteins of intact synde-
can-2 cytoplasmic domain (
 
SDC2
 
) and 
 
D
 
EFYA cytoplasmic do-
main (
 
SDC2
 
D
 
EFYA
 
, right lane) were resolved on a 10–20% tri-
cine gel, blotted, and overlaid with GST-synbindin (bottom
panel) as described in Materials and Methods. (top panel) Pon-
ceau S staining of the blot. (D) Two-hybrid assays to analyze the
syndecan-2–binding site in synbindin. Four synbindin fragments
(shown in the bottom panel) were tested with two syndecan-2
baits: one representing the intact syndecan-2 cytoplasmic domain
(
 
SDC2
 
) and the other representing the 
 
D
 
EFYA cytoplasmic do-
main (
 
SDC2
 
D
 
EFYA
 
). The interactions were scored by His pro-
totrophy (left) and 
 
b
 
-galactosidase activity (right). 
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bindin directly interacts with syndecan-2 through the
EFYA tail of syndecan-2, and that the PDZ-like segment
of synbindin is involved primarily in the interaction with
syndecan-2.
 
Syndecan-2–dependent Translocation of Synbindin in 
Hippocampal Neurons
 
To examine further the physiological significance of the
synbindin–syndecan-2 interaction in neurons, we tested
whether these two proteins interact in the cytoplasmic en-
vironment of cultured hippocampal neurons. For this, hip-
pocampal neurons at 1 DIV were transfected with synbin-
din-GFP fusion protein alone or together with syndecan-2.
The localization of synbindin and syndecan-2 was exam-
ined at 8 DIV by GFP signals and immunofluorescence
with anti–syndecan-2 antibody, respectively. At this stage
in culture, endogenous syndecan-2 is not yet expressed by
hippocampal neurons. Therefore, the syndecan-2 immu-
noreactivities detected in these experiments represent
transfected syndecan-2 (Ethell and Yamaguchi, 1999). We
found that the distribution of synbindin changes depen-
dent on cotransfection of syndecan-2. In neurons trans-
fected with synbindin-GFP alone, synbindin was distrib-
uted diffusely in cytoplasm (Fig. 3 B). In contrast, when
neurons were transfected with synbindin-GFP together
with intact syndecan-2, synbindin formed clusters along
dendrites (Fig. 3 A). Immunostaining of these double-
transfected neurons with anti–syndecan-2 antibody dem-
onstrated colocalization of synbindin and syndecan-2 (Fig.
3, C–F). These results demonstrate that not only does syn-
bindin colocalize with syndecan-2 in transfected hippo-
campal neurons, but also that syndecan-2 induces synbin-
din clustering in dendrites.
To determine the localization of the synbindin clusters,
we performed a series of double labeling experiments.
These experiments demonstrated that the synbindin clus-
ters observed in synbindin/syndecan-2 double-transfected
neurons are localized in dendritic spines. As shown in Fig.
3, double staining with anti-MAP2 antibody demonstrated
that the clusters of synbindin-GFP are localized in small
protrusions along dendrites (Fig. 3, G–J). Double staining
with the anti–synapsin I antibody revealed that synbindin
clusters exhibit partial overlap with synapsin I immunore-
activities (Fig. 4, A–D), a pattern typically seen for
postsynaptic proteins (Niethammer et al., 1998; Ethell and
Yamaguchi, 1999).
To examine if this clustering of synbindin is mediated by
the interaction with the EFYA tail of syndecan-2, as dem-
onstrated by biochemical binding studies, the same double
transfection experiments were performed with the synde-
can-2
 
D
 
EFYA deletion mutant. As shown in Fig. 4, synbin-
 
Figure 3.
 
Syndecan-2–dependent clustering of synbindin in den-
drites. (A and B) Hippocampal neurons were transfected at 1
DIV with synbindin-GFP and intact syndecan-2 (A) or synbindin-
GFP alone (B) and examined at 8 DIV on a confocal microscopy.
Note that without cotransfection of syndecan-2, synbindin-GFP is
localized diffusely within neurons (B). With cotransfection, syn-
bindin-GFP shows punctate distribution along dendrites (A). (C–
F) Hippocampal neurons cotransfected with synbindin-GFP and
 
syndecan-2 were immunostained with anti–syndecan-2 antibody.
(C, green) Synbindin-GFP; (D, red) syndecan-2; (E and F) super-
imposed views. Note that punctate immunoreactivities of synbin-
din-GFP overlap with syndecan-2 immunoreactive puncta. (G–J)
Hippocampal neurons cotransfected with synbindin-GFP and syn-
decan-2 were immunostained with anti-MAP2 antibody. (H,
green) Synbindin-GFP; (G, red) MAP2; (I and J) superimposed
views. Note that synbindin-GFP clusters are present along MAP2-
positive dendrites. Bars: (A–E and G–I) 20 
 
m
 
m; (F and J) 10 
 
m
 
m. 
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din failed to cluster in neurons double-transfected with
synbindin-GFP and the syndecan-2
 
DEFYA mutant (Fig.
4, E–H). In the syndecan-2/synbindin-GFP–cotransfected
cultures, the majority (83 6 7%) of GFP-positive neurons
showed extensive clustering (.10 clusters per cell) of syn-
bindin-GFP, whereas no cells (0%) were found to contain
.3 GFP clusters in the syndecan-2DEFYA/synbindin-
GFP–cotransfected cultures. We previously demonstrated
that the syndecan-2DEFYA mutant is expressed and
forms clusters in the same manner as the intact syndecan-2
in hippocampal neurons (Ethell and Yamaguchi, 1999).
Figure 4. Syndecan-2–mediated clustering of synbindin requires
the COOH-terminal EFYA motif. (A–D) Hippocampal neurons
cotransfected with synbindin-GFP and intact syndecan-2 were
immunostained with anti–synapsin I antibody. Cells were exam-
ined at 8 DIV for the distribution of synbindin (visualized with
GFP fluorescence) and synapsin I (visualized with RITC-labeled
secondary antibody) on a confocal microscopy. (A, red) Synapsin
I; (B, green) synbindin-GFP; and (C and D) superimposed views.
Note that synbindin-GFP exhibits a partial overlapping with syn-
apsin I puncta along dendrites. (E–H) Hippocampal neurons
were cotransfected with synbindin-GFP and the syndecan-
2DEFYA deletion mutant, and were examined as described
above. (E, red) Synapsin I; (F, green) synbindin-GFP; (G and H)
superimposed views. Note that synbindin-GFP is distributed dif-
fusely in dendritic shafts and the cell body without clustering. No
overlapping with synapsin I puncta are observed. Bars: (A–C and
E–G) 20 mm; (D and H) 10 mm.
Figure 5. Expression of synbindin mRNA. (A) Northern blot
analysis for synbindin expression in adult mouse tissues. (B) RT-
PCR analysis for synbindin expression in cultured rat hippocam-
pal neurons at 14 and 30 DIV. GAPDH, glyceraldehyde 3-phos-
phate dehydrogenase. (C–G) In situ hybridization of synbindin in
adult mouse CNS. (C) Hippocampal formation; (D) cerebral cor-
tex; (E) cerebellar cortex; (F) caudate putamen; (G) anterior
horn of the spinal cord. Bars: (C) 200 mm; (D–G) 350 mm. Ethell et al. Synbindin, A Syndecan-binding Protein in Dendritic Spines 61
Therefore, the lack of synbindin clustering in syndecan-
2DEFYA/synbindin-GFP–cotransfected neurons is not
due to the aberrant expression of the syndecan-2DEFYA
mutant. Taken together, these transfection experiments
provide further evidence for the synbindin–syndecan-2 in-
teraction through the EFYA tail of syndecan-2, and sug-
gest that syndecan-2 induces the clustering of synbindin in
dendrites.
Expression of Synbindin mRNA in the Nervous System
Northern blotting revealed a 4.4-kb transcript of synbindin
that is widely expressed in adult mouse tissues (Fig. 5 A).
Such an expression pattern is similar to those of syntenin
and CASK (Grootjans et al., 1997; Cohen et al., 1998).
RT-PCR and in situ hybridization studies demonstrated
that synbindin is strongly expressed in neurons. RT-PCR
analysis demonstrated that synbindin mRNA is expressed
in cultured hippocampal neurons at 14 and 30 DIV (Fig. 5
B), as was previously shown for syndecan-2 (Ethell and
Yamaguchi, 1999). In situ hybridization in the adult mouse
central nervous system (CNS) showed that synbindin is ex-
pressed predominantly in large neurons. In the cerebrum,
strong synbindin expression was observed in pyramidal
neurons in the CA1-CA3 regions of hippocampus (Fig. 5
C), pyramidal neurons in the cortex (Fig. 5 D), and large
neurons in the caudate putamen (Fig. 5 F). In the cerebel-
lum, Purkinje cells and neurons in the deep cerebellar nu-
clei exhibited strong synbindin expression (Fig. 5 E). Mo-
tor neurons in the spinal cord also showed strong
synbindin expression (Fig. 5 G). In contrast, synbindin
expression in smaller, granule-type neurons was much
weaker or undetectable, including granule neurons in the
dentate gyrus (Fig. 5 C) and those in the granular layer of
the cerebellar cortex (Fig. 5 E). Throughout the CNS, no
synbindin expression was detected in glial cell types.
Taken together, these observations suggest that, in the
nervous system, synbindin is expressed predominantly by
large, pyramidal-type neurons, which tend to have highly
developed dendritic arbors.
We compared spatial expression patterns of synbindin
and syndecan-2 by in situ hybridization in serial sections.
This analysis revealed that these two molecules exhibit al-
most identical expression patterns in the adult mouse
brain. In the hippocampus, syndecan-2 mRNA was de-
tected in pyramidal cells, whereas granule cells of the den-
tate gyrus exhibited much weaker signals (Fig. 6 A). In the
cerebellum, Purkinje cells express syndecan-2, but little
Figure 6. Synbindin and syndecan-2 are expressed in the same
types of neurons in adult brain. In situ hybridization was per-
formed as described in Materials and Methods for syndecan-2 (A
and E) and synbindin (B and F). C and D show the results of hy-
bridization with control (sense) probes for syndecan-2 and syn-
bindin, respectively. (A–D) Hippocampal formation; (E and F)
cerebellum. Note that the expression patterns of syndecan-2 and
synbindin are almost identical. Bars, 500 mm.
Figure 7. Immunohistochemical localization of synbindin in the
adult brain. (A) Identification of synbindin protein in adult brain.
The total brain extracts (lane 1) and bacterially produced GST-
synbindin fusion proteins (lane 2) were immunoblotted with af-
finity-purified antisynbindin polyclonal antibody. (B–F) Immu-
noperoxidase staining for synbindin in the adult mouse brain. (B)
Cerebral cortex; (C) CA3 of the hippocampus; (D) CA1 of the
hippocampus; (E) cerebellar cortex; (F) deep cerebellar nuclei.
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syndecan-2 expression was observed in granule neurons
(Fig. 6 E). This spatial expression pattern is very similar to
that of synbindin (Fig. 6, B and F).
Immunohistochemical Identification of Synbindin
In Vivo
To investigate the localization of endogenous synbindin in
vivo, we generated polyclonal antisera to synbindin. Anti-
bodies affinity-purified from this antiserum reacted with a
24-kD band in adult mouse brain extracts (Fig. 7 A, lane
1), which comigrate with synbindin released from GST-
synbindin (lane 2). In tissue sections, synbindin immu-
noreactivities were observed in various neurons in the
adult mouse brain. Strong immunoreactivities were found
in pyramidal neurons of the cerebral cortex (Fig. 7 B), py-
ramidal neurons of the hippocampus (Fig. 7, C and D),
Purkinje cells of the cerebellum (Fig. 7 E), and neurons of
the deep cerebellar nucleus (Fig. 7 F). In general, this re-
sult is consistent with the expression pattern of synbindin
mRNA demonstrated by in situ hybridization (Fig. 5).
Synbindin immunoreactivities were mainly associated with
the soma and the apical dendrites of these neurons. In the
hippocampus, strong immunoreactivities were observed in
the stratum lucidum where the dendrites of CA3 pyrami-
dal neurons are present (Fig. 7 C). In the cerebellum, the
cell bodies and apical dendrites of Purkinje neurons were
intensely labeled (Fig. 7 E).
Accumulation of Endogenous Synbindin in Spines of 
Cultured Hippocampal Neurons
We have shown previously that endogenous syndecan-2 is
concentrated in dendritic spines of cultured hippocampal
neurons after 2 wk in vitro (Ethell and Yamaguchi, 1999).
Immunocytochemistry revealed that synbindin exhibits a
similar temporal expression pattern in dendritic spines
(Fig. 8). At 7 DIV, synbindin immunoreactivity was de-
tected diffusely in the cytoplasm of the soma (Fig. 8 A). No
punctate immunoreactivity was detected at this stage. At
14 DIV, punctate immunoreactivity became apparent
along the dendrites (Fig. 8 B). The intensity of the punctate
staining grew stronger at 21 and 28 DIV (Fig. 8, C and D).
This time course is similar to that of syndecan-2 expression
in dendritic spines and that of the spine morphogenesis in
this culture system (Ethell and Yamaguchi, 1999). Double
immunostaining of 30 DIV hippocampal neurons con-
firmed the presence of endogenous synbindin in dendritic
spines (Fig. 8, E–J). Synbindin immunoreactivities corre-
spond to small protrusions along MAP2-positive dendritic
Figure 8. Localization of endogenous
synbindin in dendritic spines of cultured
hippocampal neurons. (A–D) Accumu-
lation of synbindin in dendritic spines of
hippocampal neurons. Hippocampal
neurons were stained with affinity-puri-
fied antisynbindin antibodies at 7 (A),
14 (B), 21 (C), and 28 (D) DIV. (E–G)
Double immunostaining of 30 DIV hip-
pocampal neurons with anti-MAP2 (E)
and antisynbindin (F) antibodies, and
their superimposed image (G). High
magnification views (insets) show that
synbindin signals (green) coincide with
small protrusions along MAP-2 positive
(red) dendritic shafts. (H–J) Double im-
munostaining of 30 DIV hippocampal
neurons with antisynaptophysin (H)
and antisynbindin (I) antibodies and
their superimposed image (J). High
magnification views (insets and bottom
panels) show that synbindin immunore-
activities (green) are in close apposition
with synaptophysin puncta (red), which
is a pattern typical of postsynaptic pro-
teins. Bars: (A–D) 20 mm; (E–J) 10 mm;
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shafts (Fig. 8, E–G). Double staining with antisynbindin
and antisynaptophysin antibodies showed a partial over-
lapping pattern (Fig. 8, H–J), as observed in transfected
neurons (Fig. 4, C and D). At high magnification (Fig. 8, in-
sets and bottom panels), synbindin puncta (green) are in
close apposition with synaptophysin puncta (red) but do
not completely overlap, which is a typical distribution pat-
tern for postsynaptic proteins. Taken together, these re-
sults demonstrate that endogenous synbindin molecules in
mature neurons exist in dendritic spines, which is consis-
tent with in vitro transfection studies (Figs. 3 and 4).
Unlike syndecan-2, which exhibits essentially no immu-
noreactivity on dendritic shafts in mature (30 DIV) neu-
rons (Ethell and Yamaguchi, 1999), synbindin was de-
tected within dendritic shafts and neuronal soma (Fig. 8, F
and I), even at 30 DIV. This is consistent with the immu-
nohistochemical results in which synbindin immunoreac-
tivities were observed along dendrites and in the soma
(Fig. 7). Considering that synbindin has similarities with
proteins involved in membrane trafficking, it is suspected
that synbindin may also associate with intracellular mem-
brane compartments within dendrites and cell bodies.
Endogenous Synbindin Is Enriched in Synaptic 
Membranes and Associated with Syndecan-2
To characterize the subcellular localization of synbindin,
we prepared subcellular fractions from adult mouse cortex
using a differential centrifugation procedure (Li et al.,
1996; Wang et al., 1997). Two marker proteins, PSD-95
(postsynaptic marker) and synaptophysin (synaptic vesicle
marker), were used as controls. Synbindin was fraction-
ated into the crude synaptosome fraction and further en-
riched in the synaptic membrane fraction (Fig. 9 A). The
fractionation pattern of synbindin was similar to that of
PSD-95. These results indicate that synbindin is associated
with synapses.
To obtain in vivo biochemical evidence for the synbin-
din–syndecan-2 interaction, we examined whether endog-
enous synbindin and syndecan-2 coprecipitate from brain
extracts. As shown in Fig. 9 B, anti–syndecan-2 mAb pre-
cipitated synbindin from the CHAPS extracts of the syn-
aptic membrane fraction. Taken together, these results
provide further evidence for the synbindin-syndecan-2 in-
teraction in vivo.
Ultrastructural Localization of Synbindin in Synapses 
and Intracellular Organelles
To determine the precise intracellular localization of syn-
bindin in vivo, we performed immunogold electron mi-
croscopy in the adult mouse cerebral cortex. This analysis
demonstrated synbindin immunolabeling in two distinct
structures in neurons, synapses, and intracellular mem-
brane organelles. Immunogold labeling for synbindin was
concentrated at asymmetric synapses (Fig. 10, A–D). La-
beling was seen on both pre- and postsynaptic membranes,
but the majority of the labeling was on the postsynaptic
side in close association with postsynaptic membranes.
Quantitative analysis of the distribution of gold particles
confirmed that synbindin is concentrated on the postsyn-
aptic side of synapses (Fig. 10 G). Such a distribution pat-
tern of synbindin is consistent with that of syndecan-2, as
determined by immunogold labeling (Hsueh et al., 1998).
Immunogold labeling demonstrated that synbindin is
also associated with membrane-bound compartments
within neurons (Fig. 10, H–J). Consistent with the light
microscopic findings (Fig. 7), immunogold labeling for
synbindin was observed in the soma and dendritic shafts
of cortical neurons. In these sites, labeling was associated
predominantly with various cisterns and vesicles. Dense
labeling was observed on the Golgi apparatus (Fig. 10, H
and I) and unidentified vesicles in the dendritic shaft (Fig.
10 J). Membrane compartments within dendritic spines
Figure 9. Subcellular distribution of synbindin and coimmuno-
precipitation of endogenous synbindin and syndecan-2. (A) Sub-
cellular fractions were prepared from adult mouse cerebral cor-
tex as described in Materials and Methods. Equal amounts of
proteins from each fraction were resolved in a 8–16% gel and im-
munoblotted with antisynbindin antibody, preimmune serum
(control), anti-CASK, anti–PSD-95, or antisynaptophysin anti-
body. (B) Synbindin coimmunoprecipitates with syndecan-2 from
the synaptic membrane fraction. Materials immunoprecipitated
from the synaptic membrane fraction with anti–syndecan-2 anti-
bodies and protein G–agarose (lane 2) or with protein G–agarose
only (lane 1) were separated on SDS-PAGE and immunoblotted
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were also labeled (Fig. 10 A, arrow). These observations
demonstrate that synbindin is indeed associated with in-
tracellular cisterns and vesicles, supporting the notion that
synbindin is involved in vesicular transport and membrane
trafficking in dendrites. Thus, these immunoelectron mi-
croscopy results indicate that synbindin is localized in two
distinct subcellular structures in neurons: (1) synapses
(mainly postsynaptic membranes and PSD) and (2) intra-
cellular membrane cisterns. Similar dual localization has
been reported for other cytoplasmic proteins implicated in
synaptic functions, including GRIP1 (Dong et al., 1999)
and a-actinin-2 (Wyszynski et al., 1998).
Figure 10. Immunogold localization of
synbindin in neurons of the adult rat
cerebral cortex. (A–F) Immunogold
electron microscopy of asymmetric
synapses in the adult mouse cerebral
cortex. (A–D) Labeling with affinity-
purified antisynbindin antibody. (E
and F) Negative controls labeled with
preimmune antibody. Note that syn-
bindin immunoreactive gold particles
are concentrated in synapses, mainly
on the postsynaptic membranes. Mem-
brane cisterns and vesicles within den-
dritic spines are also labeled (A, ar-
row). (G) Quantitative analysis of the
distribution of synbindin immunoreac-
tive gold particles. The horizontal axis
represents the distance in nanometers
from the middle of the synaptic cleft
(zero point). The peak of the chart co-
incides with the postsynaptic mem-
brane. Note that the highest concentra-
tions of gold particles coincide with the
postsynaptic membrane and PSD. The
bottom panel shows the background
distribution of gold particles in the
control sections. (H–J) Immunogold
electron microscopy of intracellular
membrane compartments in the neu-
rons of the adult mouse cerebral cor-
tex. (H and I) Golgi apparatus in the
soma and dendritic shaft. (J) Unidenti-
fied vesicles in the dendritic shaft.
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Discussion
In previous work, we demonstrated that syndecan-2 in-
duces the formation of morphologically mature dendritic
spines, and that this effect is mediated by the cytoplasmic
interaction through the COOH terminus of syndecan-2
(Ethell and Yamaguchi, 1999). We report here a novel
syndecan-2-binding protein, synbindin. Our results indi-
cate that synbindin is a postsynaptic protein that is likely
to be involved in intracellular vesicle transport in dendritic
spines. This suggests a possibility that syndecan-2 exerts its
effects on spine morphogenesis by recruiting synbindin-
positive membrane cisterns toward postsynaptic sites.
Synbindin, A Novel Syndecan-2–binding Protein
in Neurons
Synbindin is the third molecule, after syntenin (Grootjans
et al., 1997) and CASK (Cohen et al., 1998; Hsueh et al.,
1998), that has been shown to bind the COOH terminus of
syndecan-2. Both syntenin and CASK contain PDZ do-
mains and bind syndecan-2 through these domains. Syn-
bindin has a segment that shares homologies with PDZ
domains, and this segment is primarily involved in binding
to syndecan-2. However, this segment does not constitute
a classical PDZ domain. It remains to be determined
whether the synbindin–syndecan-2 interaction can be ex-
plained according to the well-established paradigm of the
recognition of protein COOH termini by PDZ domains.
Yet, the fact that proteins that bear homology with this
segment of synbindin are predominantly PDZ domain
proteins suggests that synbindin has some remote struc-
tural relationships with this family of proteins.
On the other hand, synbindin has clear structural rela-
tionships with proteins involved in vesicular transport and
membrane trafficking. Synbindin exhibits 43% homology
with a yeast protein, tentatively named p23 (Sacher et al.,
1998), which has been identified as a component of multi-
protein complex called TRAPP (Sacher et al., 1998). In
yeast cells, the TRAPP complex is thought to mediate the
docking and fusion of ER-to-Golgi transport vesicles.
Bet5p, which has sequence homology with synbindin (Fig.
1), is also a component of the TRAPP complex (Sacher et
al., 1998). These observations suggest that synbindin is in-
volved in membrane trafficking in neurons. Consistent
with this possibility, immunoelectron microscopy demon-
strated that synbindin is present on membrane-bound cis-
terns and vesicles within the soma and dendrites of cortical
neurons. Thus, it is likely that synbindin is involved in
membrane trafficking in neurons.
Physiological Significance of the Interaction
Despite the fact that the synbindin-syndecan-2 interaction
may not be explained by the well-established paradigm of
the interaction between PDZ domains and protein COOH
termini, there is ample evidence for the physiological sig-
nificance of the interaction. In situ hybridization and im-
munohistochemistry demonstrated that, in the CNS, syn-
bindin is expressed by certain neuronal populations, most
notably large, pyramidal-type neurons. In contrast, synbin-
din expression is weak in granular-type neurons, such as
the neurons of the dentate gyrus and the granular layer of
the cerebellum. This pattern of expression is very similar
to that of syndecan-2 (Fig. 6). In mature hippocampal neu-
rons in culture, synbindin is concentrated in dendritic
spines, as previously shown for syndecan-2 (Ethell and
Yamaguchi, 1999). Cotransfection experiments showed
that syndecan-2 causes the clustering of synbindin in den-
dritic spines, and that this syndecan-2–dependent clus-
tering of synbindin occurs through the EFYA tail of
syndecan-2. These results indicate that the synbindin–
syndecan-2 interaction occurs in the cytoplasmic environ-
ment of hippocampal neurons with the same specificity as
observed in two-hybrid assays. By immunogold electron
microscopy and biochemical fractionation, we demon-
strated that synbindin is associated with synaptic mem-
branes, mainly at the postsynaptic side, where the exist-
ence of syndecan-2 has been reported previously (Hsueh
et al., 1998; Hsueh and Sheng, 1999). Finally, synbindin
coimmunoprecipitates with syndecan-2 from the synaptic
membrane fractions. These results strongly suggest that
synbindin and syndecan-2 interact physiologically in den-
dritic spines of certain populations of neurons.
Clustering of Synbindin in Dendritic Spines
Requires Syndecan-2
In the previous study, we showed that the interaction of
the syndecan-2 and its cytoplasmic ligands is essential for
transfected syndecan-2 to induce spine formation (Ethell
and Yamaguchi, 1999). Furthermore, our work demon-
strated that the cytoplasmic syndecan-2 ligands essential
for spine formation are recruited by syndecan-2 rather
than the cytoplasmic ligands recruit syndecan-2 (Ethell
and Yamaguchi, 1999). The sorting behavior of trans-
fected synbindin in hippocampal neurons is consistent
with the following observation: the clustering of synbindin
in spines requires syndecan-2 expression (Figs. 3 and 4).
Moreover, the clustering of endogenous synbindin during
the course of hippocampal cultures is also consistent with
this notion: the clustering of synbindin in spines occurs af-
ter 2 wk in vitro, coinciding with the accumulation of syn-
decan-2 in spines (Ethell and Yamaguchi, 1999). These re-
sults indicate that syndecan-2 recruits cytoplasmic proteins
to the membrane sites that later become dendritic spines.
Thus, syndecan-2 may act as a mediator of extracellular
signals, which specify the site of prospective dendritic
spines, though we have not determined if any extracellular
ligands are involved in the syndecan-2 action on spine
morphogenesis. In this vein, it is interesting to examine
whether other intracellular syndecan-2 ligands, namely
CASK and syntenin, are also translocated to spines depen-
dent on the expression of syndecan-2. If so, the role of syn-
decan-2 may be a more general one.
Possible Role of Synbindin in Dendritic
Spine Morphogenesis
Our previous work showed that a molecule that binds to
the syndecan-2 EFYA tail plays a crucial role in the pro-
cess of syndecan-2–induced spine formation as a down-
stream effector (Ethell and Yamaguchi, 1999); however, it
is not known which molecule among the three known
EFYA ligands (syntenin, CASK, and synbindin) is rele-
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out to be irrelevant to spine formation. On the other hand,
it is possible that all three interactions occur in neurons, as
they are all expressed in neurons (Hsueh et al., 1998;
Ethell and Yamaguchi, 1999). It is also possible that these
molecules play different roles within neurons. Having
PDZ domains, CASK and syntenin are likely to be in-
volved in the assembly of the cytoskeletal scaffold. Lack-
ing the classical PDZ domain and other cytoskeletal mo-
tifs, synbindin is unlikely to be involved in the assembly of
the postsynaptic cytoskeletal scaffold. On the other hand,
the homology with the components of the yeast TRAPP
complex suggests synbindin is involved in vesicle transport
in neurons.
There is increasing evidence that membrane trafficking
plays an important role in functional maturation of
postsynaptic structures. For instance, Lledo et al. (1998)
showed that inhibition of membrane trafficking with the
botulinum toxin suppresses LTP. In dendritic spines,
AMPA receptors are present in association with intra-
cellular vesicles, and upon stimulation of synapses,
these  AMPA-containing vesicles dock and fuse with the
postsynaptic plasma membrane (Nusser et al., 1998; Shi et
al., 1999). Membrane fusion in postsynaptic sites is
thought to be mediated by N-ethylmaleimide-sensitive fu-
sion protein and SNAREs (Turner et al., 1999). Interest-
ingly, there is evidence that the TRAPP complex acts up-
stream of the SNARE complex assembly. Rossi et al.
(1995) showed that the SNARE complex does not form in
the yeast BET3 mutant, indicating that BET3 genetically
interacts with the SNARE pathway. As discussed above,
both BET3 and p23, the putative yeast homologue of syn-
bindin, are components of the TRAPP complex (Sacher et
al., 1998). This suggests that synbindin is involved in mem-
brane trafficking in postsynaptic sites.
At present, we do not know whether synbindin acts as a
downstream effector in the syndecan-2–induced spine for-
mation. Yet, there are a few possible scenarios that syn-
bindin is involved in the process of spine formation. Den-
dritic spines contain membrane-bound organelles (Villa et
al., 1992; Spacek and Harris, 1997; Gardiol et al., 1999).
These organelles, or spine apparatus, appear throughout
the spine and are sometimes seen around the lateral mar-
gins of the postsynaptic density (Harris and Stevens, 1988;
Spacek and Harris, 1997). These membrane-bound or-
ganelles are thought to play important roles in local syn-
thesis and posttranslational modification of neurotrans-
mitter receptors. Therefore, synbindin clustering induced
by syndecan-2 expression may facilitate local synthesis and
transport of neurotransmitter receptors. This may, in turn,
result in an increase in synaptic efficiency and early matu-
ration of postsynaptic structures. Another possibility,
which we currently favor, is that the synbindin–syndecan-2
interaction promotes the recruitment of Ca21-storing
membrane compartments toward synapses, and the Ca21
mobilization from these compartments induces morpho-
logical changes of spines. Membrane cisterns immunoreac-
tive for inositol trisphosphate and/or ryanodine receptors,
which identify intracellular Ca21 stores, have been shown
in dendritic spines, sometimes in the close vicinity of
postsynaptic membranes (Sharp et al., 1993; Berridge,
1998; Fagni et al., 2000). Moreover, a moderate and tran-
sient increase in [Ca21] due to release from these Ca21
stores has been shown to cause elongation of existing
spines and the formation of new ones (Korkotian and Se-
gal, 1999; Segal et al., 2000). These observations suggest
that morphogenesis of dendritic spines involves the re-
cruitment of Ca21-storing vesicles in the vicinity of syn-
apses. Therefore, the induction of spine formation by syn-
decan-2 may be due to the recruitment of synbindin-
coated Ca21-storing membrane compartments toward
subsynaptic locations. In any event, the identification of a
protein that is involved in vesicle transport as a ligand for
a cell-surface proteoglycan suggests that extracellular cues
may have a role in determining the destination of these
vesicles over dendritic surfaces, which in turn promotes
the formation of postsynaptic specialization at such a des-
tination.
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